Melsmon

Melsmon

Melsmon by Melsmon Pharmaceutical Co., Ltd. is a placenta therapy injection that has been safely practiced in Japan for 50 years. It uses the placenta of healthy donors after going through comprehensive preliminary checks.

Melsmon Injection, a type of in-placenta injection, has been used by Melsmon Japan since 1956, following its approval by the Japanese Welfare Ministry. For over 50 years, Placenta Therapy has been safe in Japan. 
The placenta used in the therapy comes from healthy donors and undergoes thorough preliminary inspections before being numbered with a unique manufacturing code. 
Moreover, the original end products are imported into Korea by Melsmon Korea Corp. It's worth noting that there have been no reports of serious side effects during the therapy's 50 years of use in Japan.

Benefits of Melsmon:

• provide a safe placenta therapy injection.
• use the placenta of healthy donors after going through comprehensive preliminary checks.